Nuance Investments Decreased Its Abbott Labs (ABT) Position; Rk Asset Management Has Lifted Globus Medical A (GMED) Position

October 28, 2017 - By Peter Erickson

Nuance Investments Llc decreased Abbott Labs (ABT) stake by 19.65% reported in 2017Q2 SEC filing. Nuance Investments Llc sold 194,556 shares as Abbott Labs (ABT)’s stock declined 3.42%. The Nuance Investments Llc holds 795,335 shares with $38.66 million value, down from 989,891 last quarter. Abbott Labs now has $96.20B valuation. The stock decreased 0.27% or $0.15 on October 27, reaching $55.37. About 4.72M shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since October 28, 2016 and is uptrending. It has underperformed by 0.80% the S&P500.

Rk Asset Management Llc increased Globus Medical Inc A (GMED) stake by 946.47% reported in 2017Q2 SEC filing. Rk Asset Management Llc acquired 107,661 shares as Globus Medical Inc A (GMED)’s stock rose 10.32%. The Rk Asset Management Llc holds 119,036 shares with $3.95M value, up from 11,375 last quarter. Globus Medical Inc A now has $3.02B valuation. The stock increased 1.00% or $0.31 on October 27, reaching $31.39. About 605,273 shares traded. Globus Medical Inc (NYSE:GMED) has risen 30.88% since October 28, 2016 and is uptrending. It has outperformed by 14.18% the S&P500.

Among 15 analysts covering Globus Medical Inc (NYSE:GMED), 8 have Buy rating, 3 Sell and 4 Hold. Therefore 53% are positive. Globus Medical Inc had 35 analyst reports since August 3, 2015 according to SRatingsIntel. The stock has “Buy” rating by Canaccord Genuity on Monday, October 23. As per Thursday, August 17, the company rating was maintained by Canaccord Genuity. The stock has “Market Perform” rating by Wells Fargo on Wednesday, July 27. The firm earned “Sell” rating on Monday, May 16 by Goldman Sachs. The rating was initiated by Morgan Stanley on Monday, September 14 with “Overweight”. Oppenheimer maintained Globus Medical Inc (NYSE:GMED) on Friday, May 5 with “Hold” rating. The stock has “Buy” rating by Canaccord Genuity on Thursday, August 3. The firm earned “Underweight” rating on Thursday, August 3 by Barclays Capital. On Wednesday, November 9 the stock rating was downgraded by JMP Securities to “Mkt Perform”. Needham initiated the stock with “Hold” rating in Tuesday, September 26 report.

Investors sentiment increased to 1.57 in 2017 Q2. Its up 0.21, from 1.36 in 2017Q1. It increased, as 25 investors sold GMED shares while 58 reduced holdings. 37 funds opened positions while 93 raised stakes. 62.65 million shares or 2.09% less from 63.99 million shares in 2017Q1 were reported. Segall Bryant Hamill Limited holds 0.25% or 324,647 shares. Sio Capital Management Limited Liability Corp invested 1.79% of its portfolio in Globus Medical Inc (NYSE:GMED). Wellington Mngmt Group Incorporated Limited Liability Partnership holds 0.04% or 5.33 million shares. Moreover, Hanseatic Mgmt Ser has 0% invested in Globus Medical Inc (NYSE:GMED). Tower Capital Limited Liability Corporation (Trc) holds 0% or 115 shares in its portfolio. Lpl Limited Liability invested in 0% or 28,441 shares. Parametrica Mgmt stated it has 0.19% in Globus Medical Inc (NYSE:GMED). Ameritas Inv Prns has 0.12% invested in Globus Medical Inc (NYSE:GMED). Ameriprise Financial Inc has 336,243 shares for 0.01% of their portfolio. Teachers Retirement Of The State Of Kentucky stated it has 63,151 shares or 0.03% of all its holdings. Strs Ohio invested 0% in Globus Medical Inc (NYSE:GMED). California Public Employees Retirement System accumulated 0% or 84,700 shares. Godshalk Welsh Capital Mngmt stated it has 2.18% of its portfolio in Globus Medical Inc (NYSE:GMED). Barclays Public Limited Company holds 0% or 47,535 shares. Gp Incorporated, a New York-based fund reported 189,846 shares.

Among 24 analysts covering Abbott Laboratories (NYSE:ABT), 14 have Buy rating, 0 Sell and 10 Hold. Therefore 58% are positive. Abbott Laboratories had 87 analyst reports since July 24, 2015 according to SRatingsIntel. On Monday, August 10 the stock rating was reinitiated by Credit Suisse with “Outperform”. The stock has “Buy” rating by Jefferies on Tuesday, October 10. Deutsche Bank maintained the stock with “Buy” rating in Friday, July 21 report. The firm has “Hold” rating by BMO Capital Markets given on Thursday, July 20. The firm has “Outperform” rating by RBC Capital Markets given on Thursday, July 23. The stock of Abbott Laboratories (NYSE:ABT) has “Neutral” rating given on Thursday, April 28 by Piper Jaffray. The rating was maintained by Jefferies on Tuesday, September 13 with “Buy”. Barclays Capital maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, April 20. Barclays Capital has “Overweight” rating and $52 target. As per Wednesday, October 7, the company rating was upgraded by Barclays Capital. Stifel Nicolaus maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, October 19. Stifel Nicolaus has “Buy” rating and $63.0 target.

Nuance Investments Llc increased California Wtr Svc Group (NYSE:CWT) stake by 140,034 shares to 321,059 valued at $11.82M in 2017Q2. It also upped Lindsay Corp (NYSE:LNN) stake by 19,571 shares and now owns 51,697 shares. Bb&T Corp (NYSE:BBT) was raised too.